Clough Capital Partners L P Pfizer Inc Transaction History

Clough Capital Partners L P

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $3.05 Million - $3.53 Million	-84,420 Reduced 55.36%	68,070 $2.5 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $5.23 Million - $6.81 Million	132,890 Added 678.01%	152,490 $6.22 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $818,300 - $1.07 Million	19,600 New	19,600 $1 Million
Q2 2022 Aug 16, 2022	SELL	$46.53 - $55.17 $6.35 Million - $7.53 Million	-136,460 Reduced 29.22%	330,540 $17.3 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $16.6 Million - $20.6 Million	362,910 Added 348.65%	467,000 $24.2 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $12.6 Million - $18.6 Million	-303,900 Reduced 74.49%	104,090 $6.15 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $16 Million - $20.5 Million	-406,710 Reduced 49.92%	407,990 $17.5 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $2.74 Million - $3.1 Million	76,300 Added 10.33%	814,700 $31.9 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $24.7 Million - $27.9 Million	738,400 New	738,400 $26.8 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $6.57 Million - $7.38 Million	-177,700 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $1.24 Million - $1.36 Million	-33,000 Reduced 15.66%	177,700 $7.55 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $5.02 Million - $5.33 Million	-151,000 Reduced 41.75%	210,700 $7.63 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $11.2 Million - $12.4 Million	361,700	361,700 $12.9 Million

3,219

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $165B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

Stay updated on Clough Capital Partners L P with notifications on news.